Production, purification and titration of a lentivirus-based vector for gene delivery purposes

被引:52
|
作者
Nasri, Masoud [1 ]
Karimi, Ali [2 ]
Farsani, Mehdi Allahbakhshian [3 ]
机构
[1] Tarbiat Modares Univ, Med Biotechnol Dept, Fac Med Sci, Tehran, Iran
[2] Shahre Kord Univ Med Sci, Med Plant Res Ctr, Shahrekord, Iran
[3] Shahid Beheshti Univ Med Sci, Fac Appl Med, Dept Hematol & Blood Banking, Tehran, Iran
关键词
Lentivirus-based vector; Transfection; Transduction; HIGH-TITER; NONDIVIDING CELLS; TRANSDUCTION; CYTOTOXICITY; GLYCOPROTEIN; PROTEIN;
D O I
10.1007/s10616-013-9652-5
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Viral vectors are valuable tools to deliver genetic materials into cells. Vectors derived from human immunodeficiency virus type 1 are being widely used for gene delivery, mainly because they are able to transduce both dividing and non-dividing cells which leads to stable and long term gene expression. In addition, these types of vectors are safe, with low toxicity, high stability and cell type specificity. Therefore, this work was aimed to produce lentivirus-based vector using a three-plasmid system. To produce this system, the eGFP marker gene was cloned into the plasmid pWPXLd. Subsequently, this vector plasmid, along with packaging plasmids, psPAX2 and envelope plasmid, pMD2.G, was co-transfected into packaging cell line (293T) using calcium phosphate method. 48 h post transfection, the constructed viral vector was harvested, purified and concentrated and stored at -80 A degrees C for next experiments. The titration of the vector was carried out, using ELISA, flowcytometry, and fluorescent microscopy. Finally, transduction of HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell lines was carried out with indicated cell numbers and multiplicities of infections of the vector in the presence of polybrene. Using this system, high titer lentivirus at titers of up to 2 x 10(8) transducing units/ml (TU/ml) was successfully generated and its transduction efficacy was improved by seven to over 20-fold in various cell types. We demonstrate the applicability of this vector for the efficient transduction of dividing and non-dividing cells, including HEK-293T, CHO, HepG2, MCF-7, MEFs and Jurkat cell line. Transduction efficiency yielded titers of (6.3 +/- A 1.2) 10(5) TU/ml. Furthermore, lentivirus transferred transgene was expressed at high level in the target cells and expression was followed until 90 days after transduction. Thus, the vector generated in this work, might be able to deliver the transgene into a wide range of mammalian cells.
引用
收藏
页码:1031 / 1038
页数:8
相关论文
共 50 条
  • [21] Lentivirus-based shRNA of Caspase-3 gene silencing inhibits chondrocyte apoptosis and delays the progression of surgically induced osteoarthritis
    Zhu, Weicong
    Yang, Xiaohong
    Liu, Shaojie
    Wang, Yiwen
    Li, Wenxu
    Zhong, Qiguang
    Zhang, Lihua
    Xu, Jiake
    BIOTECHNOLOGY JOURNAL, 2024, 19 (01)
  • [22] Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors
    Evans, JT
    Kelly, PF
    O'Neill, E
    Garcia, JV
    HUMAN GENE THERAPY, 1999, 10 (09) : 1479 - 1489
  • [23] The Effect of Lithium on Viral Vector Production and Gene Delivery
    Pla, Michelle Mendiola
    Roan, Jun-Neng
    Lee, Franklin H.
    Bowles, Dawn E.
    MOLECULAR THERAPY, 2023, 31 (04) : 243 - 243
  • [24] Development of the first WHO lentiviral vector standard: Towards the production control and standardisation of lentivirus based gene therapy products
    Zhao, Y.
    Stepto, H.
    Schneider, C. K.
    HUMAN GENE THERAPY, 2017, 28 (12) : A64 - A64
  • [25] Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer
    Ikeda, Y
    Yonemitsu, Y
    Miyazaki, M
    Goto, Y
    Sakamoto, T
    Ishibashi, T
    Ueda, Y
    Hasegawa, M
    Tobimatsu, S
    Sueishi, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1311 - U1311
  • [26] BRaf signaling principles unveiled by large-scale human mutation analysis with a rapid lentivirus-based gene replacement method
    Lim, Chae-Seok
    Kang, Xi
    Mirabella, Vincent
    Zhang, Huaye
    Bu, Qian
    Araki, Yoichi
    Hoang, Elizabeth T.
    Wang, Shiqiang
    Shen, Ying
    Choi, Sukwoo
    Kaang, Bong-Kiun
    Chang, Qiang
    Pang, Zhiping P.
    Huganir, Richard L.
    Zhu, J. Julius
    GENES & DEVELOPMENT, 2017, 31 (06) : 537 - 552
  • [27] Generation of Lentivirus Based Melanocortin α, β- and y-MSH Gene Delivery Vectors
    Eerola, Kim
    Savontaus, Eriika
    Virtanen, Sini
    Savontaus, Mikko
    MOLECULAR THERAPY, 2009, 17 : S74 - S75
  • [28] Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells
    Nishitsuji, H
    Ikeda, T
    Miyoshi, H
    Ohashi, T
    Kannagi, M
    Masuda, T
    MICROBES AND INFECTION, 2004, 6 (01) : 76 - 85
  • [29] Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: Dual gene expression in the context of HIV-2 LTR and Tat
    Sadaie, MR
    Zamani, M
    Whang, S
    Sistron, N
    Arya, SK
    JOURNAL OF MEDICAL VIROLOGY, 1998, 54 (02) : 118 - 128
  • [30] Pattern of activity of viral and housekeeping gene using self-inactivating lentivirus vector delivery into the mouse retina
    Kostic, C
    Chiodini, F
    Hornfeld, D
    Tekaya, M
    Salmon, P
    Déglon, N
    Aebischer, P
    Munier, F
    Arsenijevic, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1309 - U1309